Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term age-related effects of methylphenidate on dopaminergic brain development in ADHD
NL-OMON50336Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Prior methylphenidate exposure cohort with Prior placebo exposure cohort (2 cohorts). Primary endpoints: phMRI dopamine reactivity and medication history. Started Mar 2016; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON50336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50336.